
    
      This is a cross sectional, observational, multi-centre study to be conducted at 40 centres in
      India. The study targets to enrol 1000 patients with approx. 25 patients per site. The study
      would enrol Type 2 Diabetes Mellitus patients who provide written informed consent. No study
      medication will be prescribed or administered as a part of study procedure. Patients, who
      have been treated as per Investigators' routine clinical practice will be screened for
      enrolment in study. The study will be initiated after obtaining written approval of
      Independent Ethics Committee (IEC) /Institutional Review Board (IRB).
    
  